Randomised clinical trial: linaclotide vs placebo—a study of bi‐directional gut and brain axis

BACKGROUND: Linaclotide, a guanylate cyclase C agonist relieves irritable bowel syndrome with predominant constipation (IBS‐C) symptoms, but how it improves pain in humans is unknown. AIMS: To investigate the effects of linaclotide and placebo on the afferent and efferent gut‐brain‐gut signalling in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Aliment Pharmacol Ther
Päätekijät: Rao, Satish S.C., Xiang, Xuelian, Yan, Yun, Rattanakovit, Kulthep, Patcharatrakul, Tanisa, Parr, Rachael, Ayyala, Deepak, Sharma, Amol
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Randomised Clinical Trials
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7384154/
https://ncbi.nlm.nih.gov/pubmed/32406112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15772
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia